
New Study from Roswell Park Pinpoints Cells That May Drive Treatment Resistance in Prostate Cancer
New Study from Roswell Park Pinpoints Cells That May Drive Treatment Resistance in Prostate Cancer
Details
More Products & Services
People

Kimberly Sweeney
Roswell Park Comprehensive Cancer Center
Vice President of Patient Experience

Sai Yendamuri
Roswell Park Comprehensive Cancer Center
Chief Strategy Officer; SVP of Business Development & Outreach; Chair of Thoracic Surgery

Shashi Lele
Roswell Park Comprehensive Cancer Center
Medical Director, International Patients

Sunita Panesar
Roswell Park Comprehensive Cancer Center
Vice President of Strategy, Business Development & Outreach
Description
HIGHLIGHTS:
- Study clarifies the origin of castration-resistant prostate tumor cells
- Team identified major castration-resistant prostate epithelial cell group, L1
- Work may lead to new therapeutic targets to treat advanced prostate cancer
- Study clarifies the origin of castration-resistant prostate tumor cells
- Team identified major castration-resistant prostate epithelial cell group, L1
- Work may lead to new therapeutic targets to treat advanced prostate cancer

Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link